These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Context-dependent hormone-refractory progression revealed through characterization of a novel murine prostate cancer cell line. Watson PA; Ellwood-Yen K; King JC; Wongvipat J; Lebeau MM; Sawyers CL Cancer Res; 2005 Dec; 65(24):11565-71. PubMed ID: 16357166 [TBL] [Abstract][Full Text] [Related]
23. [Mechanism of inhibiting the proliferation of prostate cancer by finasteride: a study using cDNA microarray]. Chen G; Geng J; Zhang YF Zhonghua Yi Xue Za Zhi; 2005 Jun; 85(21):1489-92. PubMed ID: 16061029 [TBL] [Abstract][Full Text] [Related]
24. Profiling of gene expression changes caused by p53 gain-of-function mutant alleles in prostate cancer cells. Tepper CG; Gregg JP; Shi XB; Vinall RL; Baron CA; Ryan PE; Desprez PY; Kung HJ; deVere White RW Prostate; 2005 Dec; 65(4):375-89. PubMed ID: 16037992 [TBL] [Abstract][Full Text] [Related]
25. PLZF regulates Pbx1 transcription and Pbx1-HoxC8 complex leads to androgen-independent prostate cancer proliferation. Kikugawa T; Kinugasa Y; Shiraishi K; Nanba D; Nakashiro K; Tanji N; Yokoyama M; Higashiyama S Prostate; 2006 Jul; 66(10):1092-9. PubMed ID: 16637071 [TBL] [Abstract][Full Text] [Related]
26. Elevated E2F1 inhibits transcription of the androgen receptor in metastatic hormone-resistant prostate cancer. Davis JN; Wojno KJ; Daignault S; Hofer MD; Kuefer R; Rubin MA; Day ML Cancer Res; 2006 Dec; 66(24):11897-906. PubMed ID: 17178887 [TBL] [Abstract][Full Text] [Related]
27. Androgen receptor-dependent regulation of Bcl-xL expression: Implication in prostate cancer progression. Sun A; Tang J; Hong Y; Song J; Terranova PF; Thrasher JB; Svojanovsky S; Wang HG; Li B Prostate; 2008 Mar; 68(4):453-61. PubMed ID: 18196538 [TBL] [Abstract][Full Text] [Related]
28. Hormone treatment for prostate cancer: current issues and future directions. Ichikawa T; Suzuki H; Ueda T; Komiya A; Imamoto T; Kojima S Cancer Chemother Pharmacol; 2005 Nov; 56 Suppl 1():58-63. PubMed ID: 16273367 [TBL] [Abstract][Full Text] [Related]
29. Regulation of IkappaB kinase epsilon expression by the androgen receptor and the nuclear factor-kappaB transcription factor in prostate cancer. Péant B; Diallo JS; Lessard L; Delvoye N; Le Page C; Saad F; Mes-Masson AM Mol Cancer Res; 2007 Jan; 5(1):87-94. PubMed ID: 17259348 [TBL] [Abstract][Full Text] [Related]
30. Gene expression profile of mouse prostate tumors reveals dysregulations in major biological processes and identifies potential murine targets for preclinical development of human prostate cancer therapy. Haram KM; Peltier HJ; Lu B; Bhasin M; Otu HH; Choy B; Regan M; Libermann TA; Latham GJ; Sanda MG; Arredouani MS Prostate; 2008 Oct; 68(14):1517-30. PubMed ID: 18668517 [TBL] [Abstract][Full Text] [Related]
31. Hormonal regulation of beta2-adrenergic receptor level in prostate cancer. Ramberg H; Eide T; Krobert KA; Levy FO; Dizeyi N; Bjartell AS; Abrahamsson PA; Taskén KA Prostate; 2008 Jul; 68(10):1133-42. PubMed ID: 18454446 [TBL] [Abstract][Full Text] [Related]
32. [Anti-apoptotic effect of the androgen receptor in human prostate cancer]. Shen FY; Li BY Zhonghua Nan Ke Xue; 2007 Dec; 13(12):1121-4. PubMed ID: 18284065 [TBL] [Abstract][Full Text] [Related]
33. Development of an androgen-deprivation induced and androgen suppressed human prostate cancer cell line. Lee SO; Dutt SS; Nadiminty N; Pinder E; Liao H; Gao AC Prostate; 2007 Sep; 67(12):1293-300. PubMed ID: 17626246 [TBL] [Abstract][Full Text] [Related]
34. Expression of a hyperactive androgen receptor leads to androgen-independent growth of prostate cancer cells. Hsieh CL; Cai C; Giwa A; Bivins A; Chen SY; Sabry D; Govardhan K; Shemshedini L J Mol Endocrinol; 2008 Jul; 41(1):13-23. PubMed ID: 18469090 [TBL] [Abstract][Full Text] [Related]
35. Longitudinal analysis of androgen deprivation of prostate cancer cells identifies pathways to androgen independence. D'Antonio JM; Ma C; Monzon FA; Pflug BR Prostate; 2008 May; 68(7):698-714. PubMed ID: 18302219 [TBL] [Abstract][Full Text] [Related]
36. Gene amplifications associated with the development of hormone-resistant prostate cancer. Edwards J; Krishna NS; Witton CJ; Bartlett JM Clin Cancer Res; 2003 Nov; 9(14):5271-81. PubMed ID: 14614009 [TBL] [Abstract][Full Text] [Related]
37. Androgen receptor and prostate cancer: molecular aspects and gene expression profiling. Sommer A; Haendler B Curr Opin Drug Discov Devel; 2003 Sep; 6(5):702-11. PubMed ID: 14579520 [TBL] [Abstract][Full Text] [Related]
38. Suppression of androgen receptor expression by dibenzoylmethane as a therapeutic objective in advanced prostate cancer. Jackson KM; Frazier MC; Harris WB Anticancer Res; 2007; 27(3B):1483-8. PubMed ID: 17595765 [TBL] [Abstract][Full Text] [Related]
39. Androgen receptors are differentially expressed in Gleason patterns of prostate cancer and down-regulated in matched lymph node metastases. Fleischmann A; Rocha C; Schobinger S; Seiler R; Wiese B; Thalmann GN Prostate; 2011 Apr; 71(5):453-60. PubMed ID: 20878946 [TBL] [Abstract][Full Text] [Related]